Federica Martorana

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 29

Top Topics

Clinical Practice

Epidermal Growth Factor Receptor

Acute Lymphoblastic Leukemia

Hiv Infected Patients

Top Venues

International journal of molecular sciences

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Marino, Giuliana Pavone, Federica Martorana, Viviana Fisicaro, Lucia Motta, Serena Spampinato, Benedetto Maurizio Celesia, Bruno Cacopardo, Paolo Vigneri, Giuseppe Nunnari
Navigating the Nexus: HIV and Breast Cancer-A Critical Review. International journal of molecular sciences 25 (6) (2024)
Dario Piazza, Federica Martorana, Annabella Curaba, Daniela Sambataro, Maria Rosaria Valerio, Alberto Firenze, Basilio Pecorino, Paolo Scollo, Vito Chiantera, Giuseppe Scibilia, Paolo Vigneri, Vittorio Gebbia, Giuseppa Scandurra
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach. Current oncology (Toronto, Ont.) 31 (5) (2024)
Andrea Marino, Giuliana Pavone, Federica Martorana, Viviana Fisicaro, Lucia Motta, Serena Spampinato, Benedetto Maurizio Celesia, Bruno Cacopardo, Paolo Vigneri, Giuseppe Nunnari
Navigating the Nexus: HIV and Breast Cancer-A Critical Review. International journal of molecular sciences 25 (6) (2024)
Stefania Stella, Silvia Rita Vitale, Michele Massimino, Federica Martorana, Irene Tornabene, Cristina Tomarchio, Melissa Drago, Giuliana Pavone, Cristina Gorgone, Chiara Barone, Sebastiano Bianca, Livia Manzella
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients. Genes 15 (7) (2024)
Stefania Stella, Silvia Rita Vitale, Michele Massimino, Federica Martorana, Irene Tornabene, Cristina Tomarchio, Melissa Drago, Giuliana Pavone, Cristina Gorgone, Chiara Barone, Sebastiano Bianca, Livia Manzella
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients. Genes 15 (7) (2024)
Federica Martorana, Maria Vita Sanò, Maria Rosaria Valerio, Stefano Fogli, Paolo Vigneri, Romano Danesi, Vittorio Gebbia
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2- breast cancer: a critical review. Therapeutic advances in drug safety 15 (2024)
Sabrina Nucera, Chiara Conti, Federica Martorana, Brooke Wilson, Sofia Genta
Antibody-Drug Conjugates to Promote Immune Surveillance: Lessons Learned from Breast Cancer. Biomedicines 12 (7) (2024)
Sabrina Nucera, Chiara Conti, Federica Martorana, Brooke Wilson, Sofia Genta
Antibody-Drug Conjugates to Promote Immune Surveillance: Lessons Learned from Breast Cancer. Biomedicines 12 (7) (2024)
Dario Piazza, Federica Martorana, Annabella Curaba, Daniela Sambataro, Maria Rosaria Valerio, Alberto Firenze, Basilio Pecorino, Paolo Scollo, Vito Chiantera, Giuseppe Scibilia, Paolo Vigneri, Vittorio Gebbia, Giuseppa Scandurra
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach. Current oncology (Toronto, Ont.) 31 (5) (2024)
Dario Piazza, Federica Martorana, Annabella Curaba, Daniela Sambataro, Maria Rosaria Valerio, Alberto Firenze, Basilio Pecorino, Paolo Scollo, Vito Chiantera, Giuseppe Scibilia, Paolo Vigneri, Vittorio Gebbia, Giuseppa Scandurra
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach. Current oncology (Toronto, Ont.) 31 (5) (2024)
Sabrina Nucera, Chiara Conti, Federica Martorana, Brooke Wilson, Sofia Genta
Antibody-Drug Conjugates to Promote Immune Surveillance: Lessons Learned from Breast Cancer. Biomedicines 12 (7) (2024)
Stefania Stella, Silvia Rita Vitale, Michele Massimino, Federica Martorana, Irene Tornabene, Cristina Tomarchio, Melissa Drago, Giuliana Pavone, Cristina Gorgone, Chiara Barone, Sebastiano Bianca, Livia Manzella
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients. Genes 15 (7) (2024)
Andrea Marino, Giuliana Pavone, Federica Martorana, Viviana Fisicaro, Lucia Motta, Serena Spampinato, Benedetto Maurizio Celesia, Bruno Cacopardo, Paolo Vigneri, Giuseppe Nunnari
Navigating the Nexus: HIV and Breast Cancer-A Critical Review. International journal of molecular sciences 25 (6) (2024)
Federica Martorana, Maria Vita Sanò, Maria Rosaria Valerio, Stefano Fogli, Paolo Vigneri, Romano Danesi, Vittorio Gebbia
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2- breast cancer: a critical review. Therapeutic advances in drug safety 15 (2024)
Stefania Stella, Silvia Rita Vitale, Michele Massimino, Federica Martorana, Irene Tornabene, Cristina Tomarchio, Melissa Drago, Giuliana Pavone, Cristina Gorgone, Chiara Barone, Sebastiano Bianca, Livia Manzella
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients. Genes 15 (7) (2024)
Vittorio Gebbia, Maria Rosaria Valerio, Federica Martorana, Maria Vita Sanò, Paolo Vigneri
Letter to the Editor: statistics and clinical perception of patients' reported outcomes for palbociclib and abemaciclib: a sliding doors story. Journal of comparative effectiveness research (2023)
Michele Massimino, Federica Martorana, Stefania Stella, Silvia Rita Vitale, Cristina Tomarchio, Livia Manzella, Paolo Vigneri
Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer. Genes 14 (7) (2023)
Vittorio Gebbia, Federica Martorana, Giuseppina Scandurra, Maria Rosaria Valerio, Salvatore Cufari, Paolo Vigneri, Maria Vita Sanò, Paolo Scollo
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Federica Martorana, Giuseppe Di Grazia, Giovanni Nunzio Rosano, Giada Maria Vecchio, Chiara Conti, Sabrina Nucera, Gaetano Magro, Paolo Vigneri
More Than Meets the Eye: A Case of Breast Cancer Switching from Being Luminal-Androgen-Receptor-Positive to Being Hormone-Receptor-Positive. Medicina (Kaunas, Lithuania) 59 (10) (2023)
Federica Martorana, Giuseppina Scandurra, Maria Rosaria Valerio, Salvatore Cufari, Paolo Vigneri, Maria Vita Sanò, Giuseppe Scibilia, Paolo Scollo, Vittorio Gebbia
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Giuliana Pavone, Chiara Romano, Federica Martorana, Lucia Motta, Lucia Salvatorelli, Antonio Maria Zanghì, Gaetano Magro, Paolo Vigneri
Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature. Diagnostics (Basel, Switzerland) 12 (9) (2022)
Federica Martorana, Leandro Apolinario Da Silva, Cristiana Sessa, Ilaria Colombo
Everything Comes with a Price: The Toxicity Profile of DNA-Damage Response Targeting Agents. Cancers 14 (4) (2022)
Simone Di Franco, Paola Bianca, Davide Stefano Sardina, Alice Turdo, Miriam Gaggianesi, Veronica Veschi, Annalisa Nicotra, Laura Rosa Mangiapane, Melania Lo Iacono, Irene Pillitteri, Sander van Hooff, Federica Martorana, Gianmarco Motta, Eliana Gulotta, Vincenzo Luca Lentini, Emanuele Martorana, Micol Eleonora Fiori, Salvatore Vieni, Maria Rita Bongiorno, Giorgio Giannone, Dario Giuffrida, Lorenzo Memeo, Lorenzo Colarossi, Marzia Mare, Paolo Vigneri, Matilde Todaro, Ruggero De Maria, Jan Paul Medema, Giorgio Stassi
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery. Nature communications 12 (1) (2021)
Giuliana Pavone, Lucia Motta, Federica Martorana, Gianmarco Motta, Paolo Vigneri
A New Kid on the Block: Sacituzumab Govitecan for the Treatment of Breast Cancer and Other Solid Tumors. Molecules (Basel, Switzerland) 26 (23) (2021)
Ilaria Colombo, Sofia Genta, Federica Martorana, Monia Guidi, Milo Frattini, Eleftherios Pierre Pierre Samartzis, Simone Brandt, Sheila Gaggetta, Laura Moser, Mariarosa Pascale, Tatiana Terrot, Cristiana Sessa, Anastasios Stathis
Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (18) (2021)
Federica Martorana, Katia Lanzafame, Giuliana Pavone, Lucia Motta, Gianmarco Motta, Nicola Inzerilli, Rosaria Carciotto, Giada Maria Vecchio, Antonino Maria Zanghì, Héctor Josè Soto Parra, Gaetano Magro, Paolo Vigneri
Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases. Case reports in oncological medicine 2021 (2021)
Stefania Stella, Silvia Rita Vitale, Michele Massimino, Adriana Puma, Cristina Tomarchio, Maria Stella Pennisi, Elena Tirrò, Chiara Romano, Federica Martorana, Fabio Stagno, Francesco Di Raimondo, Livia Manzella
A Novel System for Semiautomatic Sample Processing in Chronic Myeloid Leukaemia: Increasing Throughput without Impacting on Molecular Monitoring at Time of SARS-CoV-2 Pandemic. Diagnostics (Basel, Switzerland) 11 (8) (2021)
Federica Martorana, Paolo Vigneri, Livia Manzella, Elena Tirrò, Héctor J Soto Parra
Delayed use of eribulin in a heavily pretreated liposarcoma patient, previously misdiagnosed as leiomyosarcoma. Future oncology (London, England) 16 (1s) (2020)
Livia Manzella, Michele Massimino, Stefania Stella, Elena Tirrò, Maria Stella Pennisi, Federica Martorana, Gianmarco Motta, Silvia Rita Vitale, Adriana Puma, Chiara Romano, Sandra Di Gregorio, Marco Russo, Pasqualino Malandrino, Paolo Vigneri
Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment. International journal of molecular sciences 20 (13) (2019)